Assembly of transferred normal spleen cells in situ at sites eliciting the delayed hypersensitivity reaction to tumor antigens in mice.

Cell assembly at sites eliciting the delayed hypersensitivity reaction (DHR) to tumor antigens was studied using 51Cr-labeled cells. C3H/He mice were strongly immunized with syngeneic MM46 tumors. The MM46 antigen fraction elicited tumor-specific DHR when injected into the footpad of MM46-immunized mice. The test mice were then injected iv with 51Cr-labeled spleen cells from normal mice, their feet were cut off, and radioactivity in the feet was counted in a gamma-scintillation counter as a measure of the assembly of 51Cr-spleen cells at the site of the antitumor DHR. Assembly of spleen cells persisted for 48 hr after injection of the antigen fraction. Local passive transfer of the DHR also induced assembly of spleen cells, indicating that it is a cell-mediated immune reaction. On the basis of these results, the role of cell movement in host defense systems against tumors is discussed.

[1]  S. Abe,et al.  Combination therapy of murine tumors with lentinan, bacterial lipopolysaccharide and a Streptococcus preparation, OK432. , 1983, Gan.

[2]  S. Abe,et al.  Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide. , 1982, Gan.

[3]  S. Abe,et al.  Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction. , 1982, Gan.

[4]  F. Kantor,et al.  Local passive transfer of delayed-type hypersensitivity in the mouse. , 1982, Journal of immunology.

[5]  S. Abe,et al.  Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors. , 1982, Gan.

[6]  V. Viklický,et al.  The reduced localization of iv-injected lymphocytes into the lymph nodes, lungs, and small intestine of allogeneic hosts is a consequence of cell destruction. , 1981, Cellular immunology.

[7]  D. Nelson,et al.  Specific triggering of macrophage accumulation at the site of secondary tumor challenge in mice with concomitant tumor immunity. , 1979, Cellular immunology.

[8]  S. Abe,et al.  Antitumor immunity after surgical removal of 3-methylcholanthrene-induced murine tumors: correlation between resistance and delayed hypersensitivity reaction. , 1978, Gan.

[9]  S. Abe,et al.  Differentiation of host-mediated antitumor agents from mitotic posons by the antitumor foot-pad reaction in Ehrlich carcinoma-ddY mouse system. , 1976, Gan.

[10]  I. Cohen,et al.  Recruitment of effector lymphocytes by initiator lymphocytes. Circulating lymphocytes are trapped in the reacting lymph node. , 1976, Journal of immunology.

[11]  J. Adams,et al.  Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens. , 1974, Journal of the National Cancer Institute.

[12]  C. Boone,et al.  Changes in the homing properties of labeled lymphoid cells caused by solid tumor growth. , 1974, Cellular immunology.

[13]  G. Asherson,et al.  Inflammatory lymphoid cells. Cells in immunized lymph nodes that move to sites of inflammation. , 1972, Immunology.

[14]  L. Old,et al.  Delayed Hypersensitivity and Transplantation Immunity elicited by Soluble Antigens of Chemically Induced Tumours in Inbred Guinea-pigs , 1968, Nature.